AKT1 and hepatocellular carcinoma: Our results suggested that the FAK/PI3K/AKT/mTOR pathway affects the activities and expressions of MMP-2 and MMP-9, further inhibiting the migration and invasion of hepatocellular carcinoma cells (Figure 5).